These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7801081)

  • 21. Critical steps in fluoroquinolones and carbapenems prescriptions: results from a prospective clinical audit.
    Seligman BG; Ribeiro RA; Kuchenbecker Rde S; Grings AO; Dos Santos RP; Machado AR; Casali FC; Guzatto F; Morais VD; Schroeder G; Küplich NM; Pires MR; Konkewicz LR; Jacoby T
    Int J Clin Pract; 2007 Jan; 61(1):147-52. PubMed ID: 16889636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost effective approach to treatment of infection: "switch therapy".
    Burnakis TG
    Hosp Pharm; 1992 Apr; 27(4):353-4, 360. PubMed ID: 10117773
    [No Abstract]   [Full Text] [Related]  

  • 23. Marketing home i.v. antibiotic therapy to physicians.
    Bernstein LH
    Caring; 1992 May; 11(5):50-2, 54, 56. PubMed ID: 10117729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis.
    van Kasteren ME; Mannien J; Kullberg BJ; de Boer AS; Nagelkerke NJ; Ridderhof M; Wille JC; Gyssens IC
    J Antimicrob Chemother; 2005 Dec; 56(6):1094-102. PubMed ID: 16234334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of oral antibiotic therapy.
    Nightingale CH; Quintiliani R
    Pharmacotherapy; 1997; 17(2):302-7. PubMed ID: 9085322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation and utilization patterns of antibiotic therapy. A study in 4 hospital departments].
    Massari P; Czernichow P; Manouvrier C; Lecomte F; Auger MP; Humbert G; Thomine JM; Courtois H; Nouvet G; Teniere P
    Rev Epidemiol Sante Publique; 1993; 41(2):161-8. PubMed ID: 8493395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The computer-assisted management programs for antibiotic therapies in connection with an application in geriatrics].
    Obez C; Barisic AM; Chatelier W; Dellamonica MC; Falcot J; Koubi C; Mondain V; Dellamonica P
    Pathol Biol (Paris); 2004 Dec; 52(10):589-96. PubMed ID: 15596308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic therapy in serious infectious states].
    Carlet J; Tabah A
    Med Mal Infect; 2006 Jun; 36(6):299-303. PubMed ID: 16698210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness issues for home i.v. therapy in the United States.
    Allen R
    Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future pharmacoeconomic criteria for the treatment of infections.
    Milkovich G
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S12-4. PubMed ID: 19560668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic therapy: what to consider when treating geriatric patients.
    Yoshikawa TT; Norman DC
    Hosp Formul; 1993 Sep; 28(9):754-6, 761-3, 766-8. PubMed ID: 10128820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S; Smith S; Newman D; Ritter W; Burke J; Ramirez JA
    Pharmacotherapy; 1997; 17(3):569-75. PubMed ID: 9165561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic aspects of antibiotic therapy].
    Internist (Berl); 1996 Jul; 37(7 Suppl Okonomisch):1-8. PubMed ID: 9541671
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacoeconomics of intravenous antibiotic use in serious infection.
    Levett PN; Jennings AM; Manning KS; Harewood HC; Griffith CR; Williams CJ; Estwick D; Lashley BA
    West Indian Med J; 1995 Sep; 44(3):81-4. PubMed ID: 8560883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic precision pays off for hospital.
    Morrissey J
    Mod Healthc; 1996 Jun; 26(25):94, 96. PubMed ID: 10158012
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease?
    Kollef MH
    Heart Lung; 1994; 23(5):363-7. PubMed ID: 7989204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.